This year marks the 15th anniversary of the completion of the Human Genome Project. In the decade and a half that has passed since, the genomic revolution has spurred an immeasurable level of excitement and support surrounding the promise of personalized medicine, setting high expectations for a new era of health care and rapidly transforming the field into a multi-billion dollar industry. While realizing that promise has turned out to be neither quick nor easy, recent scientific and technological progress has been impressive, pointing to a possible tipping point for mainstream clinical adoption as well as tremendous commercial growth potential for innovators, entrepreneurs, and investors.

For a deep-dive into this potential and how to capitalize on it, join us in South San Francisco on Thursday, December 6, 2018, for the annual Business of Personalized Medicine Summit. A unique, one-day thought leadership program now entering into its fifth year, the Summit aims to explore sustainable business model solutions for entities that are already engaged in the personalized medicine marketplace as well as those seeking to enter the competitive space. Through a series of thought-provoking discussions with key executives from across multiple stakeholder perspectives, the program examines in depth the latest financial, regulatory, policy, R&D, and technology-related complexities, trends, and opportunities impacting the business of personalized medicine, and introduces strategies for successfully navigating the challenging and ever-evolving market.

Featured panel topics to include:

• Personalized Medicine Investors: Who Are They and What Are They Thinking?
• Exploiting AI: From Discovery to Treatment
• Disruptive Technologies Creating Revolutionary Opportunities
• Collaborating With the FDA: What Has Worked and What Hasn\’t?
• Reimbursement: The Best-Laid Plans?
• The Business of Integration: Exploring the Clinical Adoption Models of Three Distinct Institutions

To register for this can’t-miss day of industry networking and thought leadership, please click here. Registration is complimentary for invited life sciences and healthcare executives, entrepreneurs, investors, and academics.